Literature DB >> 19811893

Spontaneous autoimmune myocarditis and cardiomyopathy in HLA-DQ8.NODAbo transgenic mice.

Veena Taneja1, Chella S David.   

Abstract

Most individuals have viral infections at some point in their life, however, only few develop autoreactivity to cardiac myosin following infection suggesting a genetic predisposition. Population studies have shown that among all the genetic factors linked with autoimmune disease development, MHC class II genes are the most significant genetic factors. Experimental autoimmune myocarditis resembling human Dilated cardiomyopathy can be induced in susceptible mice by infection with coxsackie virus as well as immunization with purified foreign and murine cardiac specific a-myosin. We generated transgenic mice lacking endogenous class II molecules, HLA-DR3.Abo and HLA-DQ8.Abo transgenic mice in NOD and HLA-DQ8.Abo in B10 background, to study the role of MHC in spontaneous autoimmunity. The HLA molecules in these mice are expressed on cell surface and can positively select CD4+ T cells expressing various Vb T cell receptors. NOD.DQ8 female mice spontaneously developed myocarditis and dilated cardiomyopathy. Histopathology of heart revealed mononuclear infiltrate consisting of CD4 and Mac-1+ cells and myocyte necrosis. NOD.DQ8 mice showed cellular and humoral autoreactive response to self cardiac myosin.. Depletion of CD8 and CD4 + cells suggested that CD8 T cells may act as regulatory cells while CD4 cells are required as effector cells. NOD.DR3 and B10.DQ8 mice did not develop any cardiac pathology suggesting DQ8 is required for predisposition to the spontaneous autoreactivity while NOD background influences onset and progression of disease. Thus these mice provide powerful tools to understand the role of HLA class II molecules in predisposition and onset of human diseases and to develop immunotherapy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19811893      PMCID: PMC3574900          DOI: 10.1016/j.jaut.2009.09.005

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  81 in total

1.  The significance of autoantibodies against the ADP/ATP carrier for the pathogenesis of myocarditis and dilated cardiomyopathy--clinical and experimental data.

Authors:  H P Schultheiss
Journal:  Springer Semin Immunopathol       Date:  1989

Review 2.  Autoimmune myocarditis: a paradigm of post-infection autoimmune disease.

Authors:  N R Rose; A Herskowitz; D A Neumann; N Neu
Journal:  Immunol Today       Date:  1988-04

3.  Induction of major histocompatibility complex antigens within the myocardium of patients with active myocarditis: a nonhistologic marker of myocarditis.

Authors:  A Herskowitz; A Ahmed-Ansari; D A Neumann; W E Beschorner; N R Rose; L M Soule; C L Burek; K W Sell; K L Baughman
Journal:  J Am Coll Cardiol       Date:  1990-03-01       Impact factor: 24.094

4.  Circulating heart-reactive antibodies in patients with myocarditis or cardiomyopathy.

Authors:  D A Neumann; C L Burek; K L Baughman; N R Rose; A Herskowitz
Journal:  J Am Coll Cardiol       Date:  1990-11       Impact factor: 24.094

5.  Cytolytic cross-reactive antibodies directed against the cardiac membrane and viral proteins in coxsackievirus B3 and B4 myocarditis. Characterization and pathogenetic relevance.

Authors:  B Maisch; E Bauer; M Cirsi; K Kochsiek
Journal:  Circulation       Date:  1993-05       Impact factor: 29.690

6.  Demographic features and prevalence of idiopathic myocarditis in patients undergoing endomyocardial biopsy.

Authors:  A Herskowitz; S Campbell; J Deckers; E K Kasper; J Boehmer; D Hadian; D A Neumann; K L Baughman
Journal:  Am J Cardiol       Date:  1993-04-15       Impact factor: 2.778

Review 7.  Sex differences in autoimmune disease from a pathological perspective.

Authors:  DeLisa Fairweather; Sylvia Frisancho-Kiss; Noel R Rose
Journal:  Am J Pathol       Date:  2008-08-07       Impact factor: 4.307

Review 8.  HLA class II transgenic mice mimic human inflammatory diseases.

Authors:  Ashutosh K Mangalam; Govindarajan Rajagopalan; Veena Taneja; Chella S David
Journal:  Adv Immunol       Date:  2008       Impact factor: 3.543

9.  Mice lacking MHC class II molecules.

Authors:  D Cosgrove; D Gray; A Dierich; J Kaufman; M Lemeur; C Benoist; D Mathis
Journal:  Cell       Date:  1991-09-06       Impact factor: 41.582

Review 10.  Pituitary autoimmunity: 30 years later.

Authors:  Patrizio Caturegli; Isabella Lupi; Melissa Landek-Salgado; Hiroaki Kimura; Noel R Rose
Journal:  Autoimmun Rev       Date:  2008-05-08       Impact factor: 9.754

View more
  6 in total

1.  Flexible peptide recognition by HLA-DR triggers specific autoimmune T-cell responses in autoimmune thyroiditis and diabetes.

Authors:  Cheuk Wun Li; Roman Osman; Francesca Menconi; Erlinda S Concepcion; Yaron Tomer
Journal:  J Autoimmun       Date:  2016-09-23       Impact factor: 7.094

2.  FTY720 (Gilenya) treatment prevents spontaneous autoimmune myocarditis and dilated cardiomyopathy in transgenic HLA-DQ8-BALB/c mice.

Authors:  Ferenc Boldizsar; Oktavia Tarjanyi; Katalin Olasz; Akos Hegyi; Katalin Mikecz; Tibor T Glant; Tibor A Rauch
Journal:  Cardiovasc Pathol       Date:  2016-05-17       Impact factor: 2.185

Review 3.  Understanding Autoimmune Diabetes through the Prism of the Tri-Molecular Complex.

Authors:  Matthew L Bettini; Maria Bettini
Journal:  Front Endocrinol (Lausanne)       Date:  2017-12-14       Impact factor: 5.555

Review 4.  Infectious myocarditis: the role of the cardiac vasculature.

Authors:  Linde Woudstra; Lynda J M Juffermans; Albert C van Rossum; Hans W M Niessen; Paul A J Krijnen
Journal:  Heart Fail Rev       Date:  2018-07       Impact factor: 4.214

5.  Heart disease in a mutant mouse model of spontaneous eosinophilic myocarditis maps to three loci.

Authors:  Nives Zimmermann; William J Gibbons; Shelli M Homan; Daniel R Prows
Journal:  BMC Genomics       Date:  2019-10-11       Impact factor: 3.969

Review 6.  Regulatory Role of CD4+ T Cells in Myocarditis.

Authors:  Daria Vdovenko; Urs Eriksson
Journal:  J Immunol Res       Date:  2018-06-21       Impact factor: 4.818

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.